TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE AND ASSUMPTIONS
2.5 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING INCIDENCES OF AGE-RELATED MACULAR DEGENERATION (AMD) AND RETINITIS PIGMENTOSA
4.2.2 GROWING NUMBER OF STARTUPS ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT
4.3 RESTRAINTS
4.3.1 HIGH COST ASSOCIATED WITH ARTIFICIAL RETINA IMPLANT PROCEDURES
4.4 OPPORTUNITY
4.4.1 INCREASING FUNDING & INVESTMENT FOR ARTIFICIAL RETINA IMPLANT
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 KEY PLAYERS DEVELOPING BRAIN IMPLANTS TO TREAT VISION LOSS
6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2. EPIRETINAL IMPLANTS
6.3. SUBRETINAL IMPLANTS
6.4. SUPRACHOROIDAL IMPLANTS
7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION
7.1 OVERVIEW
7.2. AGE-RELATED MACULAR DEGENERATION (AMD)
7.3. RETINITIS PIGMENTOSA
8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION
8.1 OVERVIEW
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 COMPETITOR DASHBOARD
9.3 PUBLIC PLAYERS STOCK SUMMARY
9.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.5.1 PARTNERSHIP
9.5.2 EXPANSION
9.5.3 MERGER
10 COMPANY PROFILES
10.1 VIVANI MEDICAL INC.
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 IBIONICS
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGY
10.3 NANOVISION BIOSCIENCES
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGY
10.4 SENSOR-TECH LAB
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGY
10.5 LABTICIAN OPHTHALMICS, INC
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6 OPTOBIONICS
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIES
10.7 LAMBDAVISION, INC.
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 BIONIC VISION TECHNOLOGIES
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS/SERVICES OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIES
10.9 PIXIUM VISION
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 AXORUS
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
10.11 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025–2032 (USD THOUSAND)
TABLE 3 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025–2032 (USD THOUSAND)
TABLE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, 2025–2032 (USD THOUSAND)
TABLE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025–2032 (USD THOUSAND)
TABLE 6 PUBLIC PLAYERS STOCK SUMMARY
TABLE 7 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 8 PARTNERSHIP
TABLE 9 EXPANSION
TABLE 10 MERGER
TABLE 11 VIVANI MEDICAL, INC.: PRODUCTS OFFERED
TABLE 12 VIVANI MEDICAL, INC.: KEY DEVELOPMENTS
TABLE 13 IBIONICS: PRODUCTS OFFERED
TABLE 14 NANOVISON: PRODUCTS OFFERED
TABLE 15 SENSOR-TECH LAB: PRODUCTS OFFERED
TABLE 16 LABTICIAN OPHTHALMICS, INC: PRODUCTS OFFERED
TABLE 17 OPTOBIONICS: PRODUCTS OFFERED
TABLE 18 LAMBDAVISION, INC.: PRODUCTS OFFERED
TABLE 19 BIONIC VISION TECHNOLOGIES: PRODUCTS OFFERED
TABLE 20 BIONIC VISION TECHNOLOGIES: KEY DEVELOPMENTS
TABLE 21 PIXIUM VISION: PRODUCTS OFFERED
TABLE 22 PIXIUM VISION: KEY DEVELOPMENTS
TABLE 23 AXORUS: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: STRUCTURE
FIGURE 2 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET: MARKET GROWTH FACTOR ANALYSIS
FIGURE 3 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ARTIFICIAL RETINA IMPLANT MARKET
FIGURE 4 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
FIGURE 5 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY PRODUCT TYPE, 2025 & 2032 (USD THOUSAND)
FIGURE 6 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY PRODUCT TYPE, 2025 (% SHARE)
FIGURE 7 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2025 & 2032 (USD THOUSAND)
FIGURE 8 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY APPLICATION, 2025 & 2032 (USD THOUSAND)
FIGURE 9 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET, BY REGION, 2025 & 2032 (USD THOUSAND)
FIGURE 10 GLOBAL ARTIFICIAL RETINA IMPLANT MARKET SHARE, BY REGION, 2025 (% SHARE)
FIGURE 11 COMPETITOR DASHBOARD: ARTIFICIAL RETINA MARKET
FIGURE 12 VIVANI MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 VIVANI MEDICAL, INC.: SWOT ANALYSIS
FIGURE 14 IBIONICS: SWOT ANALYSIS
FIGURE 15 LABTICIAN OPHTHALMICS, INC: SWOT ANALYSIS
FIGURE 16 LAMBDAVISION, INC.: SWOT ANALYSIS
FIGURE 17 PIXIUM VISION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 PIXIUM VISION: SWOT ANALYSIS
